Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Anti-stroke drug effective treatment for middle-ear infections, researchers say

  • Implantable micro-device to monitor oxygen in glioma to improve treatment outcomes

  • Study on neurogenesis in the olfactory bulb

  • Raising a glass to the holidays: Research finds extra alcohol sold, consumed on holidays

  • Human stem cell model reveals molecular cues critical to neurovascular unit formation

  • Scientists create mice with a major genetic cause of ALS, frontotemporal dementia

  • Blood test for Alzheimer's one step closer

  • Switching off brain circuit renders mice 'out of touch' with environment

  • Facebook status updates reveal low self-esteem and narcissism

  • Anticipating temptation may reduce unethical behavior, research finds

  •